Table 1.
TNM | FIGO | Description |
---|---|---|
Tx | Primary tumor cannot be assessed | |
T0 | No evidence of primary tumor | |
T1 | Ia | Tumor confined to the corpus uteria |
T1a | IAa | Tumor limited to the endometrium or invading less than half of the myometrium |
T1b | IB | Tumor invades one half or more of the myometrium |
T2 | II | Tumor invades cervical stroma, but does not extend beyond the uterus |
T3 | III | Local and/or regional spread |
T3a | IIIa | Tumor invades the serosa of the corpus uteri or adnexa (direct extension or metastasis) |
T3b | IIIb | Vaginal or parametrial involvement (direct extension or metastasis) |
N1, N2 | IIIC | Metastasis to pelvic or paraaortic lymph nodesb |
N1 | IIIC1 | Metastasis to pelvic lymph nodes |
N2 | IIIC2 | Metastasis to paraaortic lymph nodes with/without metastasis to pelvic lymph nodes |
T4c | IVA | Tumor invades bladder/bowel mucosa |
M1 | IVB | Distant metastasis (excluding metastasis to vagina, pelvic serosa, or adnexa) (including metastasis to inguinal lymph nodes, intra-abdominal lymph nodes other than paraaortic or pelvic nodes) |
aEndocervical glandular involvement alone should be considered stage I
bPositive cytology must be reported separately without affecting the stage
cThe presence of bullous edema is not sufficient evidence to classify as T4